Our study for the first time suggested that SIRT1 deficiency in bladder cancer cells could suppress proliferation and ROS production, as well as induce cell cycle arrest, possibly via the FOXO3a-mediated pathways. This evidence concerns the gene SIRT1 and urinary bladder cancer.